Montag & Caldwell’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-429,310
Closed -$98.9M 96
2016
Q3
$98.9M Sell
429,310
-257,725
-38% -$63M 2.08% 25
2016
Q2
$159M Buy
687,035
+95,951
+16% +$22.1M 3.24% 13
2016
Q1
$158M Sell
591,084
-134,775
-19% -$38.6M 2.91% 13
2015
Q4
$227M Sell
725,859
-43,970
-6% -$13.1M 4.19% 5
2015
Q3
$209M Sell
769,829
-235,921
-23% -$72.5M 3.48% 8
2015
Q2
$305M Sell
1,005,750
-179,254
-15% -$53.5M 4.34% 3
2015
Q1
$353M Buy
1,185,004
+504,102
+74% +$144M 4.28% 4
2014
Q4
$175M Buy
+680,902
New +$170M 1.92% 29

Other funds holding AGN

Montag & Caldwell's AGN Position: Q4 2016 in Review

Montag & Caldwell sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 429,310 shares — an estimated $98.9M sold.

Montag & Caldwell first reported a position in AGN in Q4 2014 and held it in 8 quarters. The position peaked at $353M in Q1 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Montag & Caldwell reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Montag & Caldwell sold 429,310 Allergan plc shares in Q4 2016, an estimated $98.9M.
  • Montag & Caldwell first reported a position in Allergan plc in Q4 2014 and held it in 8 quarters.
  • Montag & Caldwell's Allergan plc position peaked at $353M in Q1 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Montag & Caldwell's 13F filing for Q4 2016, filed 7 Feb 2017.